AU504978B2 - Spiro hydantion derivatives - Google Patents

Spiro hydantion derivatives

Info

Publication number
AU504978B2
AU504978B2 AU29431/77A AU2943177A AU504978B2 AU 504978 B2 AU504978 B2 AU 504978B2 AU 29431/77 A AU29431/77 A AU 29431/77A AU 2943177 A AU2943177 A AU 2943177A AU 504978 B2 AU504978 B2 AU 504978B2
Authority
AU
Australia
Prior art keywords
hydantion
spiro
derivatives
spiro hydantion
hydantion derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU29431/77A
Other languages
English (en)
Other versions
AU2943177A (en
Inventor
R Barges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU2943177A publication Critical patent/AU2943177A/en
Application granted granted Critical
Publication of AU504978B2 publication Critical patent/AU504978B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU29431/77A 1976-10-18 1977-10-06 Spiro hydantion derivatives Expired AU504978B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
USUS733,062 1976-10-18
USUS767803 1977-02-11
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (2)

Publication Number Publication Date
AU2943177A AU2943177A (en) 1979-04-12
AU504978B2 true AU504978B2 (en) 1979-11-01

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29431/77A Expired AU504978B2 (en) 1976-10-18 1977-10-06 Spiro hydantion derivatives

Country Status (29)

Country Link
JP (3) JPS5353653A (zh)
AR (1) AR220901A1 (zh)
AT (1) AT356136B (zh)
AU (1) AU504978B2 (zh)
BG (1) BG28847A3 (zh)
CA (1) CA1088945A (zh)
CH (1) CH625511A5 (zh)
DD (1) DD131931A5 (zh)
DE (4) DE2759927C2 (zh)
DK (1) DK150302C (zh)
ES (1) ES463267A1 (zh)
FI (1) FI62307C (zh)
FR (1) FR2367754A1 (zh)
GB (1) GB1566171A (zh)
GR (1) GR70201B (zh)
HK (1) HK53881A (zh)
IE (1) IE45805B1 (zh)
IL (1) IL53094A0 (zh)
KE (1) KE3167A (zh)
LU (1) LU78330A1 (zh)
MX (1) MX4899E (zh)
MY (1) MY8200157A (zh)
NL (1) NL167434C (zh)
NO (1) NO148453C (zh)
NZ (1) NZ185358A (zh)
PH (1) PH15639A (zh)
PT (1) PT67164B (zh)
SE (1) SE437024B (zh)
YU (1) YU40821B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
WO2003088915A2 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
NL167434C (nl) 1981-12-16
HK53881A (en) 1981-11-13
JPS5495575A (en) 1979-07-28
NL7711358A (nl) 1978-04-20
FI62307B (fi) 1982-08-31
JPS607997B2 (ja) 1985-02-28
JPS5940388B2 (ja) 1984-09-29
JPS5495570A (en) 1979-07-28
IE45805L (en) 1978-04-18
LU78330A1 (fr) 1979-06-01
MY8200157A (en) 1982-12-31
FI62307C (fi) 1982-12-10
MX4899E (es) 1982-12-14
ATA745977A (de) 1979-09-15
DK461377A (da) 1978-04-19
NO148453B (no) 1983-07-04
CH625511A5 (en) 1981-09-30
PT67164B (en) 1979-03-20
DK150302B (da) 1987-02-02
AU2943177A (en) 1979-04-12
CA1088945A (en) 1980-11-04
DE2746244C2 (de) 1983-05-19
AR220901A1 (es) 1980-12-15
DE2759543C2 (de) 1987-04-09
JPS5353653A (en) 1978-05-16
FR2367754A1 (fr) 1978-05-12
ES463267A1 (es) 1978-07-16
IL53094A0 (en) 1977-12-30
SE437024B (sv) 1985-02-04
PH15639A (en) 1983-03-11
FR2367754B1 (zh) 1982-07-09
DD131931A5 (de) 1978-08-09
DE2759927C2 (de) 1986-12-04
GB1566171A (en) 1980-04-30
DE2746244A1 (de) 1978-04-20
IE45805B1 (en) 1982-12-01
NO148453C (no) 1983-10-12
NL167434B (nl) 1981-07-16
YU40821B (en) 1986-06-30
SE7711053L (sv) 1978-04-19
GR70201B (zh) 1982-08-31
DK150302C (da) 1987-09-28
KE3167A (en) 1981-11-06
FI773060A (fi) 1978-04-19
PT67164A (en) 1977-11-01
YU244277A (en) 1982-08-31
BG28847A3 (en) 1980-07-15
AT356136B (de) 1980-04-10
NZ185358A (en) 1979-06-08
DE2759542C2 (zh) 1988-07-07
JPS5534132B2 (zh) 1980-09-04
NO773548L (no) 1978-04-19

Similar Documents

Publication Publication Date Title
AU509073B2 (en) Novel tetracyclic derivatives
AU504978B2 (en) Spiro hydantion derivatives
AU519064B2 (en) 4-n-acylfortimicin b derivatives
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU504526B2 (en) Pipeazine derivatives
AU514765B2 (en) Benzopyrane derivatives
AU517829B2 (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU512647B2 (en) Solpenamide derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU2576877A (en) Hydantoin derivatives
AU516804B2 (en) 2-cyclopropyl amino-4-formamido-6-amino-s-triazine derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU495377B2 (en) 3-nitropyrazole derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives